Litcius/Paper detail

NSD2 inhibitors rewire chromatin to treat lung and pancreatic cancers

Jinho Jeong, Simone Hausmann, Hanyang Dong, Kacper Szczepski, Natasha Flores, Andy Garcia Gonzalez, Liyang Shi, Xiaoyin Lu, Joanna K. Lempiäinen, Moritz Jakab, Liyong Zeng, Tourkian Chasan, Eric Bareke, Rui Dong, Emma Carlson, Reinnier Padilla, Dylan Husmann, J. M. T. Thompson, Gerry A. Shipman, Emily Zahn, Courtney A. Barnes, Laiba F Khan, Liz Albertorio-Sáez, Eva Brill, Vishnu Udayakumar Sunita Kumary, Matthew R. Marunde, Danielle N Maryanski, Cheryl C Szany, Bryan J. Venters, Carolina Lin Windham, Michał Nowakowski, Iwona Czaban, Mariusz Jaremko, Michael‐Christopher Keogh, Kang Le, Michael Soth, Benjamin A. Garcia, Łukasz Jaremko, Jacek Majewski, Paweł K. Mazur, Or Gozani

2025Nature11 citationsDOIOpen Access PDF

Topics & Concepts

ChromatinLungCancer researchBiologyGeneticsMedicineComputational biologyInternal medicineGeneEpigenetics and DNA MethylationChromatin Remodeling and CancerCancer-related gene regulation
NSD2 inhibitors rewire chromatin to treat lung and pancreatic cancers | Litcius